These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2164203)
1. [Chemotherapy of small cell bronchial cancer with a combination of carboplatin, vincristine and etoposide]. Gatzemeier U; Achterrath W; Heckmayr M; Hossfeld DK; Neuhauss R; Reck M; Zschaber R Pneumologie; 1990 Feb; 44 Suppl 1():584-5. PubMed ID: 2164203 [TBL] [Abstract][Full Text] [Related]
2. Etoposide/vincristine-based chemotherapy with or without carboplatin in extensive-stage small cell lung cancer: a prospective randomized phase III trial. Gatzemeier U; Pawel JV; Laumen R; Hossfeld DK; Neuhauss R Semin Oncol; 1994 Jun; 21(3 Suppl 6):31-5. PubMed ID: 8052871 [TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995. Lee YC; McCrystal MR; Christmas TI N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564 [TBL] [Abstract][Full Text] [Related]
4. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial. Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of small cell lung cancer]. Fukuoka M; Negoro S; Takada M; Kusunoki Y; Matsui K; Ryu S; Sakai N; Yamamoto H; Masuda N; Takifuji N Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):966-72. PubMed ID: 2839116 [TBL] [Abstract][Full Text] [Related]
7. Experience of a German multicenter study group with ifosfamide in small cell lung cancer. Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648 [TBL] [Abstract][Full Text] [Related]
8. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer. Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368 [TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer. Shepherd FA; Evans WK; MacCormick R; Feld R; Yau JC Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma. Hainsworth JD; Stroup SL; Greco FA Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up. Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811 [TBL] [Abstract][Full Text] [Related]
13. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer. Birch R; Weaver CH; Hainsworth JD; Bobo C; Greco FA Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138 [TBL] [Abstract][Full Text] [Related]
14. [Carboplatin-Vepeside in the treatment of non-small cell bronchial cancers. A phase II study]. Heckmayr M; Gatzemeier U; Hossfeld DK; Achterrath W Pneumologie; 1990 Feb; 44 Suppl 1():588-9. PubMed ID: 2164205 [TBL] [Abstract][Full Text] [Related]
15. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment]. Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304 [TBL] [Abstract][Full Text] [Related]
16. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials. Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience. Hainsworth JD; Burris HA; Greco FA Semin Oncol; 2001 Apr; 28(2 Suppl 4):43-7. PubMed ID: 11479897 [TBL] [Abstract][Full Text] [Related]
18. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy. Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527 [TBL] [Abstract][Full Text] [Related]
19. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update. Ettinger DS Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial. Greco FA; Thompson DS; Morrissey LH; Erland JB; Burris HA; Spigel DR; Joseph G; Corso SW; Spremulli E; Hainsworth JD Oncologist; 2005 Oct; 10(9):728-33. PubMed ID: 16249353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]